Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation.

BMC cancer - 12 Sept 2018

Fernandes Gustavo S, Girardi Daniel M, Bernardes João Paulo G, Fonseca Felipe P, Fregnani Eduardo R

Abstract excerpt

BACKGROUND: Ameloblastoma is a slow-growing neoplasm of the jaw, for which the standard treatment is surgical removal of the lesion with high recurrence rates and elevated morbidity. Systemic therapy is not established in the literature. CASE PRESENTATION: We present a case of a 29-year-old woman diagnosed with an ameloblastoma of the left mandible who had been subjected to several surgical procedures over twenty...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ameloblastoma
Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Jaw Neoplasms

Share to Magnetic Resonance Imaging

Share to Molecular Targeted Therapy

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 30208863
DOI: 10.1186/s12885-018-4802-y
PMCID: PMC6134697

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation.PMID 30208863Read ↗

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature.Semantic proximity Read ↗

Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres.Semantic proximity Read ↗

High frequency of BRAF V600E mutation in Iranian population ameloblastomas.Semantic proximity Read ↗

BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution.Semantic proximity Read ↗

Does BRAF mutation status and related clinicopathological factors affect the recurrence rate of ameloblastoma? A systematic review, meta-analysis and metaregression.Semantic proximity Read ↗

Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta-analysis.Semantic proximity Read ↗

Effectiveness of molecular-targeted chemotherapy in ameloblastomas: A systematic review.Semantic proximity Read ↗

Managing stage 4 ameloblastoma with dual BRAF/MEK inhibition: A case report with 8-year clinical follow-up.Semantic proximity Read ↗

Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas.Semantic proximity Read ↗

Precision therapy for BRAF V600E-mutated ameloblastoma: Systematic review insights.Semantic proximity Read ↗

Analysis of BRAF V600E expression and disease-free survival in patients with ameloblastoma.Semantic proximity Read ↗

Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.